Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
MERRIMACK PHARMACEUTICALS INC has filed 807 SEC EDGAR filings since 29 Dec 2003

SEC filing history

Showing 276-300 of 802 matching filings.

Per page
25
Current page
12
4

FORM 4 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35409

8-K

Filing date
15 Jun 2018
Reporting date
12 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86778

SC 13G/A filing

Filing date
10 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35409

8-K

Filing date
08 May 2018
Reporting date
08 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
27 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35409

DEFA14A

Filing date
27 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35409

DEF 14A

Filing date
27 Apr 2018
Reporting date
12 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-35409

PRER14A

Filing date
26 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-35409

PRE 14A

Filing date
13 Apr 2018
Reporting date
12 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86778

THE SCHEDULE 13G

Filing date
10 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35409

FORM 8-K

Filing date
29 Mar 2018
Reporting date
27 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223577

S-8

Filing date
12 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35409

8-K

Filing date
12 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35409

FORM 8-K

Filing date
16 Feb 2018
Reporting date
15 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2018
Reporting date
15 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2018
Reporting date
15 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2018
Reporting date
15 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2018
Reporting date
15 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2018
Reporting date
15 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86778

CONSONANCE CAPITAL MANAGEMENT LP

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .